Get my own profile
Public access
View all3 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Carlos Alberto MontanariUniversity of Sao PauloVerified email at usp.br
- Andrei LeitãoProfessor Associado - Instituto de Química de São Carlos, Universidade de São PauloVerified email at iqsc.usp.br
- Peter WillettEmeritus professor, University of SheffieldVerified email at sheffield.ac.uk
- Alexander BreezeUniversity of LeedsVerified email at leeds.ac.uk
- Niklas BlombergDirector, ELIXIRVerified email at ebi.ac.uk
- Antonio Carlos Bender BurtolosoProfessor do Instituto de Química de São Carlos, Universidade de São PauloVerified email at iqsc.usp.br
- Carolina Borsoi MoraesDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University ofVerified email at usp.br
- Ed GriffenMedChemica LtdVerified email at medchemica.com
- Rutger FolmerSymeres (Mercachem)Verified email at symeres.com
- Stefan GeschwindnerDirector Biophysics, Mechanistic & Structural Biology, AstraZeneca R&D GothenburgVerified email at astrazeneca.com
- Jonathan BowyerPharmaceutical R&D ConsultantVerified email at jonathanbowyer.com
- James J. CrawfordAltos Labs, Strathclyde University, The Scripps Research InstituteVerified email at altoslabs.com
- robert c. glenCambridge University and Imperial College LondonVerified email at cam.ac.uk
- Dorin ToaderDirector at Mersana TherapeuticsVerified email at mersana.com
- Julie TuckerUniversity of YorkVerified email at york.ac.uk
- William Borges FernandesAluno de doutorado, Universidade de São PauloVerified email at iqsc.usp.br
- J. Willem M. Nissinkassociate directorVerified email at artios.com
- Tom PeatUNSWVerified email at unsw.edu.au
- Mark FurberRIA iMED, ASTRAZENECAVerified email at astrazeneca.com
- Olan DolezalCSIROVerified email at csiro.au